<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7366108\results\search\testTrace\results.xml">
  <result pre="cardiovascular, gastrointestinal, immune, and hepatic complications, are associated with COVID-19" exact="infection" post="along with prominent respiratory disease including pneumonia. Extensive research"/>
  <result pre="â€¢COVID-19 is an emerging viral pandemic with no specific clinical" exact="treatment" post="available. â€¢COVID-19 induces respiratory, neurological, cardiovascular, renal, and hepatic"/>
  <result pre="and trans-signaling in endothelial cells [[17], [18], [19], [20]]. SARS-CoV-2" exact="infection" post="cause final release and increase in pro-inflammatory cytokines, including"/>
  <result pre="even death. Several epidemiological, genetic, and clinical elements of COVID-19" exact="infection" post="resemble previous SARS-CoV and MERS-CoV infection [23]. Ironically, even"/>
  <result pre="clinical elements of COVID-19 infection resemble previous SARS-CoV and MERS-CoV" exact="infection" post="[23]. Ironically, even after the frequent re-emergence of CoVs"/>
  <result pre="(also known as endoribonuclease EndoU) is vital for restraining the" exact="detection" post="of viral RNA by specific cytoplasmic pattern recognition receptors"/>
  <result pre="CVD may become more severe in the presence of viral" exact="infection" post="because of the imbalance between the increased metabolic demand"/>
  <result pre="system and one of best in target enzymes for the" exact="treatment" post="of hypertension. The protease renin converts angiotensinogen to angiotensin"/>
  <result pre="as a cellular entry receptor [15,39] and the degree of" exact="infection" post="caused by SARS-CoV-2 in heart or other cardiovascular tissues"/>
  <result pre="restlessness loss of smell (anosmia), and taste (dysgeusia) due to" exact="infection" post="in the brain [[17], [18], [19], [20]]. The neurological"/>
  <result pre="been seen in patients with COVID-19 as proof of brain" exact="infection" post="due to this SARS-CoV-2 [[17], [18], [19], [20]]. Still,"/>
  <result pre="is a question for scientists or neurologist that the brain" exact="infection" post="due to COVID-19 play a role in respiratory trouble"/>
  <result pre="similarities between SARS-CoV and COVID-19 for following the pathway of" exact="infection" post="[[17], [18], [19], [20]]. Guillain-Barre syndrome (GBS) associated with"/>
  <result pre="understanding of the possible link between the brain and respiratory" exact="infection" post="by COVID-19, and clinical reports or biopsy studies may"/>
  <result pre="and clinical reports or biopsy studies may conclude that brain" exact="infection" post="involved or not in respiratory failure. 4.3 Impact of"/>
  <result pre="(367 men and 334 women) for the assessment of the" exact="prevalence" post="of ARI in COVID-19 patients as well as for"/>
  <result pre="renal complications [53]. Moreover, the same study concluded that the" exact="prevalence" post="of renal complications during hospital admission as well as"/>
  <result pre="effects of SARS-CoV-2 on kidney tissue, as evidenced by the" exact="detection" post="of SARS-CoV-2 fragments in blood and urine in patients"/>
  <result pre="a moderate level of microvascular steatosis indicates that either SARS-CoV-2" exact="infection" post="or drug used during treatment was the possible cause"/>
  <result pre="steatosis indicates that either SARS-CoV-2 infection or drug used during" exact="treatment" post="was the possible cause for liver injury [68,69]. In"/>
  <result pre="of COVID-19 patients (nÂ =Â 4243) from 6 countries reported" exact="prevalence" post="of all GI symptoms, including loss of appetite, nausea/vomiting,"/>
  <result pre="diarrhea. Due to 80% similarity to SARS-CoV, SARS-CoV-2 persuaded GIT" exact="infection" post="is not surprising and is specified to be mediated"/>
  <result pre="various alternatives and therapies which were earlier used for the" exact="treatment" post="of SARS such as anti-biotics, anti-viral, and steroidal drugs"/>
  <result pre="anti-viral, and steroidal drugs are widely being used for the" exact="treatment" post="of COVID-19 [11,47,48]. 4.5 Impact of COVID-19 on diabetic"/>
  <result pre="established that diabetic population is at high-risk group for viral" exact="infection" post="due to hyperglycemia-induced increased oxidative stress as well as"/>
  <result pre="a retrospective study conducted in the first epicenter of COVID-19" exact="infection" post="(Wuhan) confirmed that about 10% of the COVID-19 patients"/>
  <result pre="depicting data from 2108 Chinese COVID-19 patients concluded that the" exact="prevalence" post="of diabetes in COVID-19 patients is 10.3%, which is"/>
  <result pre="COVID-19 patients is 10.3%, which is similar to the diabetic" exact="prevalence" post="in healthy population [76]. Therefore, it can be concluded"/>
  <result pre="patients, but the predisposition of the diabetic population to SARS-CoV-2" exact="infection" post="may not be higher as compared to healthy people."/>
  <result pre="pancreatic destruction in COVID-19 patients. The development of a viral" exact="infection" post="in diabetic patients renders them harder to treat due"/>
  <result pre="secondary diabetic complications. Therefore, it can be hypothesized that the" exact="treatment" post="of COVID-19 cum diabetic patients with ACE-2 stimulatory drugs"/>
  <result pre="mellitus and hypertension, genetically predisposes towards increased risk of SARS-COV-2" exact="infection" post="[94]. In a nutshell, intake of ACE inhibitors may"/>
  <result pre="physiological adaptive changes render pregnant women more susceptible to COVID-19" exact="infection" post="than the general population [79]. In this context, a"/>
  <result pre="pneumonia and some proof of vertical maternal-fetal transmission of SARS-CoV-2" exact="infection" post="[81]. A recent study on pediatric patients with COVID-19"/>
  <result pre="including oxygen and ventilation support [11,47,48,85]. The quest for efficient" exact="treatment" post="is proceeding with numerous investigations ongoing across the world."/>
  <result pre="Summary of the completed clinical trials of repurposed drugs for" exact="treatment" post="of COVID-19. Table 1 Sr. no Drug name Target/rationale"/>
  <result pre="of the potential repurposed drugs currently in clinical trials for" exact="treatment" post="of COVID-19. Table 2 Sr. no Potential drug candidate"/>
  <result pre="Antiviral active against influenza viruses FDA approved anti-viral medication for" exact="treatment" post="of influenza A and influenza B flu in Japan"/>
  <result pre="polymerase against various viruses, including coronaviruses Favipiravir is approved for" exact="treatment" post="of influenza in Japan National Clinical Trial Identifier:(NCT04336904), (NCT04349241),"/>
  <result pre="against SARS-CoV-1 and MERS-CoV; showed protection in animal studies for" exact="treatment" post="of MERS-CoV Lopinavir/Ritonavir is an FDA approved antiretroviral drug"/>
  <result pre="drug of the protease inhibitor class used to treat HIV" exact="infection" post="National Clinical Trial Identifier:(NCT04307693), (NCT04276688), (NCT04328012) 4. Oseltamivir Anti-viral"/>
  <result pre="activity against various viruses, including coronaviruses Umifenovir is an antiviral" exact="treatment" post="used for influenza infection used in Russia and China."/>
  <result pre="including coronaviruses Umifenovir is an antiviral treatment used for influenza" exact="infection" post="used in Russia and China. National Clinical Trial Identifier:(NCT04252885),"/>
  <result pre="cofactor for numerous physiologic reactions; may support host defenses against" exact="infection" post="and protect host cells against infection induced oxidative stress"/>
  <result pre="support host defenses against infection and protect host cells against" exact="infection" post="induced oxidative stress Ascorbic acid is clinically used to"/>
  <result pre="oxide Selective pulmonary vasodilator; may be useful in the adjunctive" exact="treatment" post="of acute respiratory distress syndrome (ARDS), a potential complication"/>
  <result pre="human monoclonal antibody against the interleukin-6 receptor used for the" exact="treatment" post="of rheumatoid arthritis. National Clinical Trial Identifier:(NCT04357808), (NCT04315298) 15."/>
  <result pre="COVID-19 infections.1 Renin Angiotensin Aldosterone System Inhibitor, clinically approved for" exact="treatment" post="of hypertension. National Clinical Trial Identifier:(NCT04312009) 17. Anticoagulants (low"/>
  <result pre="as a novel therapy, neither can be considered the best" exact="treatment" post="option but can be considered as a possible emergency"/>
  <result pre="treatment option but can be considered as a possible emergency" exact="treatment" post="for fulminant COVID-19. In the context of plasma therapy,"/>
  <result pre="3 Summary of the clinical trials of Convalescent Plasma for" exact="treatment" post="of COVID-19. Table 3 Sr. no Plasma intervention/treatment Sponsor"/>
  <result pre="COVID-19 The development of a new vaccine to contain COVID-19" exact="infection" post="is conceivably the safest way to end this pandemic."/>
  <result pre="shield against CoV as it has been seen that after" exact="infection" post="with CoVs, there may be chances of re-infection with"/>
  <result pre="Table 4 Summary of the clinical trials of vaccines for" exact="treatment" post="of COVID-19. Table 4 Sr. no Vaccine intervention/treatment Sponsor"/>
  <result pre="perspectives and conclusion Despite enormous worldwide endeavors to restrict COVID-19" exact="infection" post="caused by SARS-CoV-2, the virus's spread has achieved an"/>
  <result pre="The source of the outbreak, the intermediate host, an effective" exact="treatment" post="regimen, tools for early diagnosis in asymptomatic patients, and"/>
  <result pre="the intermediate host, an effective treatment regimen, tools for early" exact="diagnosis" post="in asymptomatic patients, and tools to predict the emergence"/>
  <result pre="Therefore, in addition to clinical trials of new drugs and" exact="testing" post="repurposed drugs, an exceptional strategy is urgently required for"/>
  <result pre="update on the statusMilitary Medical Research7202011010.1186/s40779-020-00240-031928528 47WuY.XuX.ChenZ.DuanJ.HashimotoK.YangL.YangC.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronavirusesBrain Behav. Immun.202010.1016/j.bbi.2020.03.031 48WuR.WangL.KuoH.C.ShannarA.PeterR.ChouP.J.LiS.HudlikarR.LiuX.LiuZ.PoianiG.J.An update"/>
  <result pre="novel coronavirus disease with encephalitisChinaXiv202003202000015 51NetlandJ.MeyerholzD.K.MooreS.CassellM.PerlmanS.Severe acute respiratory syndrome coronavirus" exact="infection" post="causes neuronal death in the absence of encephalitis in"/>
  <result pre="&amp;amp; Du, B. (2020). Clinical characteristics of 2019 novel coronavirus" exact="infection" post="in China. MedRxiv. doi:10.1056/NEJMoa2002032. 66Chai, X., Hu, L., Zhang,"/>
  <result pre="acute respiratory distress syndromeLancet Respir. Med.8202042042210.1016/S2213-2600(20)30076-X32085846 70CheungK.S.HungI.F.ChanP.P.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.TamA.R.YipC.C.Gastrointestinal manifestations of SARS-CoV-2" exact="infection" post="and virus load in fecal samples from the Hong"/>
  <result pre="(2019). Spectrum of clinical and radiographic findings in patients with" exact="diagnosis" post="of H1N1 and correlation with clinical severity. BMC Infect."/>
  <result pre="disease 2019 (COVID-19): a reviewJama202010.1001/jama.2020.6019 86https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment. 87https://www.europeanpharmaceuticalreview.com/news/121787/glenmark-approved-to-supply-favipiravir-as-covid-19-treatment-in-india/. 88https://www.ashp.org/-/media/assets/pharmacy-practice/resourcecenters/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx?. 89KeithP.DayM.PerkinsL.MoyerL.HewittK.WellsA.A novel" exact="treatment" post="approach to the novel coronavirus: an argument for the"/>
 </snippets>
</snippetsTree>
